May 17, 2022, 11:05am
The Food and Drug Administration gave the go-ahead for a booster dose of Pfizer-BioNTech's Covid-19 vaccine for children ages 5-11, expanding access to the youngest age group yet after the agency allowed children ages 12-15 to get a booster earlier this year.
The Centers for Disease Control and Prevention will make a recommendation before children in the age group can get the boosters.
According to multiple reports, the Advisory Committee on Immunization Practices is expected to discuss the booster for children during a meeting on Thursday.
According to the New York Times, the CDC is likely to recommend the booster dose after the meeting, and shots could start for children in the age group as early as Friday.
The story will be updated.